[1]
Goktas Aydin, S., Kavak, E.E., Topcu, A., Bayramgil, A., Akgul, F., Kahraman, S., Aykan, M.B., Altıntas, Y.E., Helvaci, K., Urun, Y., Bilici, A. , Seker, M., Sendur, M.A.N., Olmez, O.F., Acikgoz, O. and Cicin, I. 2023. Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study. Biomolecules and Biomedicine. 23, 6 (Nov. 2023), 1089–1095. DOI:https://doi.org/10.17305/bb.2023.9253.